Selected research
Industry Growth & Trends
Global Pyrazinamide Industry Growth and Trends Forecast to 2032
Market perspective
The global Pyrazinamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pyrazinamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pyrazinamide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pyrazinamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pyrazinamide include Beijing Ouhe Technology, Energy Chemical, Waterstone Technology, Toronto Research Chemicals, TCI, Pure Chemistry Scientific, Meryer (Shanghai) Chemical Technology, LGM Pharma and J & K SCIENTIFIC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pyrazinamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pyrazinamide market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pyrazinamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pyrazinamide.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pyrazinamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pyrazinamide Market by Company
Beijing Ouhe Technology
Energy Chemical
Waterstone Technology
Toronto Research Chemicals
TCI
Pure Chemistry Scientific
Meryer (Shanghai) Chemical Technology
LGM Pharma
J & K SCIENTIFIC
HBCChem
EDQM
City Chemical
AlliChem
Alfa Chemistry
Acros Organics
Pyrazinamide Segment by Type
Purity 98%
Purity 99%
Others
Pyrazinamide Segment by Application
Children
Adult
Pyrazinamide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pyrazinamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pyrazinamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pyrazinamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pyrazinamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pyrazinamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 98%
- Purity 99%
- Others
Applications
- Children
- Adult
Companies covered
- Beijing Ouhe Technology
- Energy Chemical
- Waterstone Technology
- Toronto Research Chemicals
- TCI
- Pure Chemistry Scientific
- Meryer (Shanghai) Chemical Technology
- LGM Pharma
- J & K SCIENTIFIC
- HBCChem
- EDQM
- City Chemical
- AlliChem
- Alfa Chemistry
- Acros Organics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pyrazinamide Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pyrazinamide Sales Estimates and Forecasts (2021-2032)
- 1.3 Pyrazinamide Market by Type
- 1.3.1 Purity 98%
- 1.3.2 Purity 99%
- 1.3.3 Others
- 1.4 Global Pyrazinamide Market Size by Type
- 1.4.1 Global Pyrazinamide Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pyrazinamide Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pyrazinamide Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pyrazinamide Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pyrazinamide Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pyrazinamide Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pyrazinamide Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pyrazinamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pyrazinamide Industry Trends
- 2.2 Pyrazinamide Industry Drivers
- 2.3 Pyrazinamide Industry Opportunities and Challenges
- 2.4 Pyrazinamide Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pyrazinamide Revenue (2021-2026)
- 3.2 Global Top Players by Pyrazinamide Sales (2021-2026)
- 3.3 Global Top Players by Pyrazinamide Price (2021-2026)
- 3.4 Global Pyrazinamide Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pyrazinamide Major Company Production Sites & Headquarters
- 3.6 Global Pyrazinamide Company, Product Type & Application
- 3.7 Global Pyrazinamide Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pyrazinamide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pyrazinamide Players Market Share by Revenue in 2025
- 3.8.3 2025 Pyrazinamide Tier 1, Tier 2, and Tier 3
4 Pyrazinamide Regional Status and Outlook
- 4.1 Global Pyrazinamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pyrazinamide Historic Market Size by Region
- 4.2.1 Global Pyrazinamide Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pyrazinamide Sales in Value by Region (2021-2026)
- 4.2.3 Global Pyrazinamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pyrazinamide Forecasted Market Size by Region
- 4.3.1 Global Pyrazinamide Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pyrazinamide Sales in Value by Region (2027-2032)
- 4.3.3 Global Pyrazinamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pyrazinamide by Application
- 5.1 Pyrazinamide Market by Application
- 5.1.1 Children
- 5.1.2 Adult
- 5.2 Global Pyrazinamide Market Size by Application
- 5.2.1 Global Pyrazinamide Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pyrazinamide Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pyrazinamide Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pyrazinamide Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pyrazinamide Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pyrazinamide Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pyrazinamide Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pyrazinamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Beijing Ouhe Technology
- 6.1.1 Beijing Ouhe Technology Company Information
- 6.1.2 Beijing Ouhe Technology Business Overview
- 6.1.3 Beijing Ouhe Technology Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Beijing Ouhe Technology Pyrazinamide Product Portfolio
- 6.1.5 Beijing Ouhe Technology Recent Developments
- 6.2 Energy Chemical
- 6.2.1 Energy Chemical Company Information
- 6.2.2 Energy Chemical Business Overview
- 6.2.3 Energy Chemical Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Energy Chemical Pyrazinamide Product Portfolio
- 6.2.5 Energy Chemical Recent Developments
- 6.3 Waterstone Technology
- 6.3.1 Waterstone Technology Company Information
- 6.3.2 Waterstone Technology Business Overview
- 6.3.3 Waterstone Technology Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Waterstone Technology Pyrazinamide Product Portfolio
- 6.3.5 Waterstone Technology Recent Developments
- 6.4 Toronto Research Chemicals
- 6.4.1 Toronto Research Chemicals Company Information
- 6.4.2 Toronto Research Chemicals Business Overview
- 6.4.3 Toronto Research Chemicals Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Toronto Research Chemicals Pyrazinamide Product Portfolio
- 6.4.5 Toronto Research Chemicals Recent Developments
- 6.5 TCI
- 6.5.1 TCI Company Information
- 6.5.2 TCI Business Overview
- 6.5.3 TCI Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 TCI Pyrazinamide Product Portfolio
- 6.5.5 TCI Recent Developments
- 6.6 Pure Chemistry Scientific
- 6.6.1 Pure Chemistry Scientific Company Information
- 6.6.2 Pure Chemistry Scientific Business Overview
- 6.6.3 Pure Chemistry Scientific Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pure Chemistry Scientific Pyrazinamide Product Portfolio
- 6.6.5 Pure Chemistry Scientific Recent Developments
- 6.7 Meryer (Shanghai) Chemical Technology
- 6.7.1 Meryer (Shanghai) Chemical Technology Company Information
- 6.7.2 Meryer (Shanghai) Chemical Technology Business Overview
- 6.7.3 Meryer (Shanghai) Chemical Technology Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Meryer (Shanghai) Chemical Technology Pyrazinamide Product Portfolio
- 6.7.5 Meryer (Shanghai) Chemical Technology Recent Developments
- 6.8 LGM Pharma
- 6.8.1 LGM Pharma Company Information
- 6.8.2 LGM Pharma Business Overview
- 6.8.3 LGM Pharma Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 LGM Pharma Pyrazinamide Product Portfolio
- 6.8.5 LGM Pharma Recent Developments
- 6.9 J & K SCIENTIFIC
- 6.9.1 J & K SCIENTIFIC Company Information
- 6.9.2 J & K SCIENTIFIC Business Overview
- 6.9.3 J & K SCIENTIFIC Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 J & K SCIENTIFIC Pyrazinamide Product Portfolio
- 6.9.5 J & K SCIENTIFIC Recent Developments
- 6.10 HBCChem
- 6.10.1 HBCChem Company Information
- 6.10.2 HBCChem Business Overview
- 6.10.3 HBCChem Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 HBCChem Pyrazinamide Product Portfolio
- 6.10.5 HBCChem Recent Developments
- 6.11 EDQM
- 6.11.1 EDQM Company Information
- 6.11.2 EDQM Business Overview
- 6.11.3 EDQM Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 EDQM Pyrazinamide Product Portfolio
- 6.11.5 EDQM Recent Developments
- 6.12 City Chemical
- 6.12.1 City Chemical Company Information
- 6.12.2 City Chemical Business Overview
- 6.12.3 City Chemical Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 City Chemical Pyrazinamide Product Portfolio
- 6.12.5 City Chemical Recent Developments
- 6.13 AlliChem
- 6.13.1 AlliChem Company Information
- 6.13.2 AlliChem Business Overview
- 6.13.3 AlliChem Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 AlliChem Pyrazinamide Product Portfolio
- 6.13.5 AlliChem Recent Developments
- 6.14 Alfa Chemistry
- 6.14.1 Alfa Chemistry Company Information
- 6.14.2 Alfa Chemistry Business Overview
- 6.14.3 Alfa Chemistry Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Alfa Chemistry Pyrazinamide Product Portfolio
- 6.14.5 Alfa Chemistry Recent Developments
- 6.15 Acros Organics
- 6.15.1 Acros Organics Company Information
- 6.15.2 Acros Organics Business Overview
- 6.15.3 Acros Organics Pyrazinamide Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Acros Organics Pyrazinamide Product Portfolio
- 6.15.5 Acros Organics Recent Developments
7 North America by Country
- 7.1 North America Pyrazinamide Sales by Country
- 7.1.1 North America Pyrazinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pyrazinamide Sales by Country (2021-2026)
- 7.1.3 North America Pyrazinamide Sales Forecast by Country (2027-2032)
- 7.2 North America Pyrazinamide Market Size by Country
- 7.2.1 North America Pyrazinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pyrazinamide Market Size by Country (2021-2026)
- 7.2.3 North America Pyrazinamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pyrazinamide Sales by Country
- 8.1.1 Europe Pyrazinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pyrazinamide Sales by Country (2021-2026)
- 8.1.3 Europe Pyrazinamide Sales Forecast by Country (2027-2032)
- 8.2 Europe Pyrazinamide Market Size by Country
- 8.2.1 Europe Pyrazinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pyrazinamide Market Size by Country (2021-2026)
- 8.2.3 Europe Pyrazinamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pyrazinamide Sales by Country
- 9.1.1 Asia-Pacific Pyrazinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pyrazinamide Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pyrazinamide Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pyrazinamide Market Size by Country
- 9.2.1 Asia-Pacific Pyrazinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pyrazinamide Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pyrazinamide Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pyrazinamide Sales by Country
- 10.1.1 South America Pyrazinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pyrazinamide Sales by Country (2021-2026)
- 10.1.3 South America Pyrazinamide Sales Forecast by Country (2027-2032)
- 10.2 South America Pyrazinamide Market Size by Country
- 10.2.1 South America Pyrazinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pyrazinamide Market Size by Country (2021-2026)
- 10.2.3 South America Pyrazinamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pyrazinamide Sales by Country
- 11.1.1 Middle East and Africa Pyrazinamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pyrazinamide Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pyrazinamide Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pyrazinamide Market Size by Country
- 11.2.1 Middle East and Africa Pyrazinamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pyrazinamide Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pyrazinamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pyrazinamide Value Chain Analysis
- 12.1.1 Pyrazinamide Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pyrazinamide Production Mode & Process
- 12.2 Pyrazinamide Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pyrazinamide Distributors
- 12.2.3 Pyrazinamide Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst